Evidence map›Paper›PMID 24644057›Full record

ArticleAngewandte Chemie (International ed. in English)2014

Particle display: a quantitative screening method for generating high-affinity aptamers.

Jinpeng Wang, Qiang Gong, Nupur Maheshwari, Michael Eisenstein, Mary Luz Arcila, Kenneth S Kosik, H Tom Soh

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Advances in aptamer technology for target-based drug discovery.Journal of pharmaceutical analysis · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Functional Selection of Tau Oligomerization-Inhibiting Aptamers.Angewandte Chemie (International ed. in English) · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis.Frontiers in cellular and infection microbiology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jinpeng WangDepartment of Mechanical Engineering, Materials and Institute for Collaborative Biotechnologies, University of California, Santa Barbara, CA 93106 (USA).
Qiang Gong
Nupur Maheshwari
Michael Eisenstein
Mary Luz Arcila
Kenneth S Kosik
H Tom Soh

Funding

Midwest Progenitor Cell ConsortiumU01HL099773 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI THOMSON, JAMES ALEXANDER · 2009 to 2015
$7.8M
QPASS: Quantitative Parallel Aptamer Selection SystemU54DK093467 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SMITH, LLOYD M, SOH, HYONGSOK TOM · 2011 to 2013
$3.2M
Polypeptide Design with Proteomic Scope via Microfluidic mRNA DisplayR01AI085583 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERTS, RICHARD W, SOH, HYONGSOK TOM · 2009 to 2013
$2.4M
NHLBI NIH HHS U01 HL099773NIAID NIH HHS R01 AI085583NIDDK NIH HHS U54 DK093467PHS HHS R01A1076899PHS HHS U01 L099773-01
6 · The paper itself

Abstract

We report an aptamer discovery technology that reproducibly yields higher affinity aptamers in fewer rounds compared to conventional selection. Our method (termed particle display) transforms libraries of solution-phase aptamers into "aptamer particles", each displaying many copies of a single sequence on its surface. We then use fluorescence-activated cell sorting (FACS) to individually measure the relative affinities of >10(8) aptamer particles and sort them in a high-throughput manner. Through mathematical analysis, we identified experimental parameters that enable optimal screening, and demonstrate enrichment performance that exceeds the theoretical maximum achievable with conventional selection by many orders of magnitude. We used particle display to obtain high-affinity DNA aptamers for four different protein targets in three rounds, including proteins for which previous DNA aptamer selection efforts have been unsuccessful. We believe particle display offers an extraordinarily efficient mechanism for generating high-quality aptamers in a rapid and economic manner, towards accelerated exploration of the human proteome.

Indexed as

Aptamers, NucleotideCell SeparationFlow CytometryAptamers, Nucleotideaptamersdirected evolutionhigh-throughput screeningSELEX

Identifiers

PMID24644057
PMCPMC4065591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.